Combination chemotherapy with irinotecan and cisplatin in elderly patients (≥65 years) with extensive-disease small-cell lung cancer-Reference-Cited by-同舟云学术

Combination chemotherapy with irinotecan and cisplatin in elderly patients (≥65 years) with extensive-disease small-cell lung cancer

Published:2008-08 Issue:2 Volume:61 Page:220-226
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Kim Hoon-Gu,Lee Gyeong-Won,Kang Jung Hun,Kang Myung-Hee,Hwang In-Gyu,Kim Seok Hyun,Hahm Jong Ryeal,Jeong Yi Yeong,Kim Ho-Cheol,Lee Jong Duk,Lee Jong-Seok,Hwang Young Sil

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference28 articles.

1. Cancer statistics, 2007;Jemal;CA Cancer J Clin,2007

2. 139 KCCR-affiliated Hospitals. 2002 Annual Report of the Korea Central Cancer Registry: Based on Registered Data from 139 Hospitals;Shin;Cancer Res Treat,2004

3. Chemotherapy for elderly patients with advanced non-small-cell lung cancer;Bunn;J Natl Cancer Inst,2003

4. Surveillance, Epidemiology, and End Results (SEER): Cancer Statistics Review 1975–2004, National Cancer Institute. Bethesda, MD. http://www.seer.cancer.gob/csr/1975_2004/.

5. Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: analysis of the surveillance, epidemiologic, and end results database;Govindan;J Clin Oncol,2006

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A systematic review of survival following anti-cancer treatment for small cell lung cancer;Lung Cancer;2020-03

2. Retrospective study of irinotecan/cisplatin followed by etoposide/cisplatin or the reverse sequence in extensive-stage small cell lung cancer;OncoTargets and Therapy;2015-08

3. Current status of CPT and its analogues in the treatment of malignancies;Phytochemistry Reviews;2015-02-19

4. Is neoadjuvant chemotherapy mandatory for limited-disease small-cell lung cancer?;Interactive CardioVascular and Thoracic Surgery;2014-08-24

5. Liposomal Co-Delivery of Omacetaxine Mepesuccinate and Doxorubicin for Synergistic Potentiation of Antitumor Activity;Pharmaceutical Research;2014-02-22